Zydus Lifesciences Ltd
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Filing Details / Description
Zydus Announces Positive Topline Results from Completed EVIDENCES-X Phase II(b) Clinical Trial of Saroglitazar Mg in MASH.